Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howard, E. W.
Right arrow Articles by Knauer, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howard, E. W.
Right arrow Articles by Knauer, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 261, Issue 2, 684-689, 01, 1986

Human protease nexin-I. Further characterization using a highly specific polyclonal antibody

EW Howard and DJ Knauer

We have used purified protease nexin-I (PN-I) from human fibroblasts to develop a polyclonal antibody that specifically blocks the PN-I- mediated cellular binding of thrombin and urokinase. Anti-PN-I IgG did not inhibit the binding of 125I-epidermal growth factor-binding protein to fibroblasts, which is mediated by protease nexin-II, another cell- secreted, serine protease inhibitor that is distinct from PN-I. This furthers the belief that the protease nexins are distinct from one another. In addition, while anti-PN-I IgG immunoprecipitated PN-I X thrombin complexes, it did not do so with antithrombin-III X thrombin. Metabolically labeled PN-I was also immunoprecipitated by IgG, indicating that the protein can be labeled in vivo. The antibody also recognized primarily one band on Western transfers of conditioned medium from fibroblast cultures. These results suggest that anti-PN-I will be useful in probing the physiological role of PN-I as well as its biosynthesis.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. F. Knauer, S. J. Kridel, S. B. Hawley, and D. J. Knauer
The Efficient Catabolism of Thrombin-Protease Nexin 1 Complexes Is a Synergistic Mechanism That Requires Both the LDL Receptor-related Protein and Cell Surface Heparins
J. Biol. Chem., November 14, 1997; 272(46): 29039 - 29045.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. Knauer, S. B. Hawley, and D. J. Knauer
Identification of a Binding Site in Protease Nexin I (PN1) Required for the Receptor Mediated Internalization of PN1-Thrombin Complexes
J. Biol. Chem., May 9, 1997; 272(19): 12261 - 12264.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Riewald, K. A. Morgenstern, and R. R. Schleef
Identification and Characterization of the Cytoplasmic Antiproteinase (CAP) in Human Platelets
J. Biol. Chem., March 22, 1996; 271(12): 7160 - 7167.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Knauer, D. Majumdar, P.-C. Fong, and M. F. Knauer
SERPIN Regulation of Factor XIa. THE NOVEL OBSERVATION THAT PROTEASE NEXIN 1 IN THE PRESENCE OF HEPARIN IS A MORE POTENT INHIBITOR OF FACTOR XIa THAN C1 INHIBITOR
J. Biol. Chem., November 22, 2000; 275(48): 37340 - 37346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement